Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!

Ticker
COO.MX

Price
1723.00
Stock movement up
+- (%)
Company name
The Cooper Companies Inc.
Exchange
(MX
,
Currency
MXN
)
Sector
Healthcare >
Medical Instruments & Supplies
Markkapitalisasie
343.88B
Ondernemingswaarde
347.95B
Prys/Verkope
90.40
Prys/Boek
43.39
Dividendopbrengs
-
Dividendgroei
-
Groei jare
-
FCF uitbetaling
0.79%
Agterlopende P/E
957.09
Volgende P/E
-
PEG
-
EPS groei
15.88%
1 jaar opbrengs
0.72%
3 jaar opbrengs
-39.42%
5 jaar opbrengs
-23.52%
10 jaar opbrengs
-3.15%
Laaste opgedateer: 2025-04-05

DIVIDENDE

COO.MX betaal nie dividende nie of geen data is ontvang nie

WAARDERING

Waarderingsverhoudings

Loading...
Waarderingsverhoudings gegewens
Agterlopende P/E957.09
Prys tot OCF558.79
Prys tot FCF1817.56
Prys tot EBITDA1484.81
EV tot EBITDA1502.39

Waardering (Verkope/Boekwaarde)

Loading...
Waardering (Verkope/Boekwaarde) gegewens
Prys tot verkope90.40
Prys tot Boekwaarde43.39
EV tot verkope91.47

FINANSIËLE

Per aandeel

Loading...
Per aandeel gegewens
Huidige aandeeltelling199.58M
EPS (TTM)1.80
FCF per aandeel (TTM)0.95

Inkomstestaat

Loading...
Inkomstestaat gegewens
Inkomste (TTM)3.80B
Bruto wins (TTM)2.52B
Bedryfsinkomste (TTM)643.00M
Netto inkomste (TTM)359.30M
EPS (TTM)1.80
EPS (1j vorentoe)-

Marges

Loading...
Marges gegewens
Bruto marge (TTM)66.36%
Bedryfsmarge (TTM)16.90%
Winsgrens (TTM)9.45%

Balansstaat

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
Kontant109.70M
Netto debiteure739.00M
Totale bedryfsbates1.93B
Klandisiewaarde3.78B
Ontasbare bates1.79B
Eiendom, aanleg en toerusting0.00
Totale bates12.11B
Rekeninge betaalbaar222.00M
Kort/huidige langtermynskuld0.00
Totale bedryfslaste969.50M
Totale laste4.18B
Aandeelhouersbelang7.93B
Netto tasbare bates0.00

Kontantvloei

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
Bedryfskontantvloei (TTM)615.40M
Kapitale uitgawes (TTM)426.20M
Vrye kontantvloei (TTM)189.20M
Dividende betaal (TTM)1.50M

Finansiële opbrengste

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
Opbrengs op ekwiteit4.53%
Opbrengs op bates2.97%
Opbrengs op belegde kapitaal3.42%
Kontant opbrengs op belegde kapitaal1.80%

AANDELE INLIGTING

Aandele grafiek

Loading...
Aandele prys data
Open1723.00
Daaglikse hoog1723.00
Daaglikse laag1723.00
Daaglikse volume0K
Hoogtepunt van alle tye8625.00
1j analiseraaming-
Beta0.94
EPS (TTM)1.80
Dividend per aandeel-
Ex-dividend datum22 Jul 2019
Volgende verdienste datum28 May 2025

Afwaartse potensiaal

Loading...
Afwaartse potensiaal gegewens
COO.MXS&P500
Huidige prysdaling vanaf die hoogste punt van alle tye-80.02%-7.90%
Hoogste prysdaling-82.32%-56.47%
Datum van hoogste daling2 May 20249 Mar 2009
Gemiddelde daling vanaf hoogtepunt-13.45%-11.07%
Gemiddelde tyd tot nuwe hoogtepunt3 days12 days
Maksimum tyd tot nuwe hoogtepunt822 days1805 days
MAATSKAPPY BESONDERHEDE
COO.MX (The Cooper Companies Inc.) company logo
Markkapitalisasie
343.88B
Markkapitalisasie kategorie
Large-cap
Beskrywing
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Werknemers
15000
Beleggerverhoudings
-
CEO
Land
Mexico
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
CooperCompanies’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $80.68 per share. This was partly driven by its softer quarterly results and migh...
3 April 2025
We came across a bullish thesis on The Cooper Companies, Inc. (NASDAQ:COO) on ValueInvestorsClub by dsteiner84. In this article, we will summarize the bulls’ thesis on COO. The company’s shares were t...
17 Maart 2025
The Cooper Companies (NasdaqGS: COO) experienced a 14.56% decline in its share price last week following its recent earnings announcement. Notably, the company reported solid growth, with first-quarte...
14 Maart 2025
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers.
13 Maart 2025
The S&P 500 added 0.6% on Friday, March 7, after the February jobs report showed a slight recovery in hiring from the previous month.
7 Maart 2025
Cooper Companies (NasdaqGS:COO) recently reported improved financials with Q1 FY2025 sales rising to $965 million and net income growing to $104 million. The company's projection for fiscal 2025 reven...
7 Maart 2025
Shares of medical device company CooperCompanies (NASDAQ:COO) fell 8.1% in the pre-market session after the company reported weak fourth quarter results: revenue missed, which is never a good sign. EP...
7 Maart 2025
COO's top line fails to meet market expectations despite recording strong growth. However, improvement in operating margin bodes well.
7 Maart 2025
The Cooper Companies Inc (COO) reports robust Q1 performance with significant gains in revenue and strategic product expansions, despite facing challenges in China and fertility markets.
7 Maart 2025
The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall S...
6 Maart 2025
Volgende bladsy